<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39453787</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2060</ISSN><JournalIssue CitedMedium="Internet"><Volume>56</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Annals of medicine</Title><ISOAbbreviation>Ann Med</ISOAbbreviation></Journal><ArticleTitle>Role of new vaccinators/pharmacists in life-course vaccination.</ArticleTitle><Pagination><StartPage>2411603</StartPage><MedlinePgn>2411603</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2411603</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1080/07853890.2024.2411603</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Vaccines against diseases such as herpes zoster, pneumococcus and influenza are broadly recommended for older adults, but uptake is frequently low.</AbstractText><AbstractText Label="VACCINATION BOTTLENECK" NlmCategory="UNASSIGNED">Part of the reason may be that access to adult vaccination can be problematic, particularly for minorities and other under-served populations. Potential barriers include complex procedures, limited resources in healthcare systems and lack of structured infrastructure.</AbstractText><AbstractText Label="STRESS-TESTING EXPENDED VACCINATION" NlmCategory="UNASSIGNED">The Covid-19 pandemic necessitated rapid expansion of the infrastructure to deliver adult vaccination, and triggered the use of facilities including pharmacies, schools, faith-based organizations, community organizations, shops and hair salons, drive-through centres and mobile vaccination units.</AbstractText><AbstractText Label="IMPROVED ADULT VACCINATION SYSTEM" NlmCategory="UNASSIGNED">Although many such initiatives were temporary, they demonstrated the principle of effective expansion of adult vaccination and education to a range of new providers and settings. Of these, pharmacist involvement in immunization in particular has consistently been shown to be associated with increased immunization rates.</AbstractText><AbstractText Label="INTEGRATION OF NEW VACCINATORS" NlmCategory="UNASSIGNED">This review discusses results from attempts to expand and simplify the adult vaccination process, potentially allowing vaccination to be initiated by the recipient and completed in a single visit. These studies suggest that expanding adult vaccination access to new providers and/or new settings will require development of an integrated plan for preventive healthcare, covering areas such as setting target coverage rates, financial support, and development of immunization information systems accessible to all vaccination providers to maintain accurate immunization records and support interventions such as reminders.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mark Doherty</LastName><ForeName>T</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-3009-7969</Identifier><AffiliationInfo><Affiliation>GSK, Wavre, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Privor-Dumm</LastName><ForeName>Lois</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Johns Hopkins Bloomberg School of Public Health, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ann Med</MedlineTA><NlmUniqueID>8906388</NlmUniqueID><ISSNLinking>0785-3890</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="Y">Vaccination</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010595" MajorTopicYN="Y">Pharmacists</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000600" MajorTopicYN="N">supply &amp; distribution</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D024382" MajorTopicYN="N">Professional Role</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006297" MajorTopicYN="N">Health Services Accessibility</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017589" MajorTopicYN="N">Immunization Programs</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="plain-language-summary" Language="eng"><AbstractText>The expansion of adult vaccination to settings outside of conventional doctors’ offices and hospitals showed that other settings, with appropriate controls, can safely be used for vaccinationAvailability of adult vaccination through a range of providers and settings could simplify the vaccination process, potentially allowing vaccination to be more easily initiated by the recipientHowever, in many countries this potential is not utilized due to the need for changes to basic infrastructure and legislation covering aspects such as vaccine education, payment for vaccination, and access to immunization information systems.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Pharmacists</Keyword><Keyword MajorTopicYN="N">life-course vaccination</Keyword><Keyword MajorTopicYN="N">vaccinators</Keyword></KeywordList><CoiStatement>Timothy Mark Doherty is an employee of GSK and holds financial equities in GSK. LPD received fees from GSK for consulting. The authors declare no other financial and non-financial relationships and activities.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>22</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>22</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>12</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39453787</ArticleId><ArticleId IdType="doi">10.1080/07853890.2024.2411603</ArticleId><ArticleId IdType="pmc">PMC11514396</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Talbird SE, La EM, Carrico J, et al. . Impact of population aging on the burden of vaccine-preventable diseases among older adults in the United States. Hum Vaccin Immunother. 2021;17(2):332–343. doi: 10.1080/21645515.2020.1780847.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2020.1780847</ArticleId><ArticleId IdType="pmc">PMC7899694</ArticleId><ArticleId IdType="pubmed">32758069</ArticleId></ArticleIdList></Reference><Reference><Citation>Pham TH, Beck E, Postma MJ, et al. . Country score tool to assess readiness and guide evidence generation of immunization programs in aging adults in Europe. Front Public Health. 2023;10:1080678. doi: 10.3389/fpubh.2022.1080678.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.1080678</ArticleId><ArticleId IdType="pmc">PMC9869118</ArticleId><ArticleId IdType="pubmed">36699900</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonanni P, Bonaccorsi G, Lorini C, et al. . Focusing on the implementation of 21st century vaccines for adults. Vaccine. 2018;36(36):5358–5365. doi: 10.1016/j.vaccine.2017.07.100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2017.07.100</ArticleId><ArticleId IdType="pubmed">28807604</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams SR, Driscoll AJ, LeBuhn HM, et al. . National routine adult immunisation programmes among World Health Organization Member States: an assessment of health systems to deploy COVID-19 vaccines. Euro Surveill. 2021;26(17):2001195. doi: 10.2807/1560-7917.ES.2021.26.17.2001195.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2021.26.17.2001195</ArticleId><ArticleId IdType="pmc">PMC8086245</ArticleId><ArticleId IdType="pubmed">33928899</ArticleId></ArticleIdList></Reference><Reference><Citation>Privor-Dumm L, Vasudevan P, Kobayashi K, et al. . Archetype analysis of older adult immunization decision-making and implementation in 34 countries. Vaccine. 2020;38(26):4170–4182. doi: 10.1016/j.vaccine.2020.04.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2020.04.027</ArticleId><ArticleId IdType="pmc">PMC7252137</ArticleId><ArticleId IdType="pubmed">32376108</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan L. Adult vaccination: now is the time to realize an unfulfilled potential. Hum Vaccine Immunother. 2015;11(9):2158–2166. doi: 10.4161/21645515.2014.982998.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/21645515.2014.982998</ArticleId><ArticleId IdType="pmc">PMC4635860</ArticleId><ArticleId IdType="pubmed">26091249</ArticleId></ArticleIdList></Reference><Reference><Citation>Stratoberdha D, Gobis B, Ziemczonek A, et al. . Barriers to adult vaccination in Canada: a qualitative systematic review. Can Pharm J (Ott). 2022;155(4):206–218. doi: 10.1177/17151635221090212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17151635221090212</ArticleId><ArticleId IdType="pmc">PMC9266373</ArticleId><ArticleId IdType="pubmed">35813527</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . Summary of WHO Position Papers – recommendations for Routine Immunization 2024; [cited 2024 Aug 28]. Available from: https://cdn.who.int/media/docs/default-source/immunization/immunization_schedules/table_1_april_2024_english.pdf?sfvrsn=2e112cea_2&amp;download=true.</Citation></Reference><Reference><Citation>Wallace AS, Ryman TK, Privor-Dumm L, et al. . Leaving no one behind: defining and implementing an integrated life course approach to vaccination across the next decade as part of the immunization Agenda 2030. Vaccine. 2024;42 Suppl 1(Suppl 1):S54–S63. doi: 10.1016/j.vaccine.2022.11.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2022.11.039</ArticleId><ArticleId IdType="pmc">PMC10414185</ArticleId><ArticleId IdType="pubmed">36503859</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta B, Chawla S, Kumar V, et al. . Adult immunization: the need to address. Hum Vaccin Immunother. 2014;10(2):306–309. doi: 10.4161/hv.26797.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/hv.26797</ArticleId><ArticleId IdType="pmc">PMC4185890</ArticleId><ArticleId IdType="pubmed">24128707</ArticleId></ArticleIdList></Reference><Reference><Citation>Branswell H.
‘We’re absolutely making it too hard’: the complexity of adult immunization delivery hinders vaccine uptake 2023; [cited 2024 Jan 6]. Available from: https://www.statnews.com/2023/10/25/adult-vaccines-flu-covid-tdap-complexity/.</Citation></Reference><Reference><Citation>Lu PJ, Hung MC, Srivastav A, et al. . Surveillance of vaccination coverage among adult populations – United States, 2018. MMWR Surveill Summ. 2021;70(3):1–26. doi: 10.15585/mmwr.ss7003a1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.ss7003a1</ArticleId><ArticleId IdType="pmc">PMC8162796</ArticleId><ArticleId IdType="pubmed">33983910</ArticleId></ArticleIdList></Reference><Reference><Citation>Assistant Secretary for Planning and Evaluation (ASPE) . Disparities in COVID-19 Vaccination Rates across Racial and Ethnic Minority Groups in the United States 2021; [cited 2021 July 26]. Available from: https://aspe.hhs.gov/reports/disparities-covid-19-vaccination-rates-across-racial-ethnic-minority-groups-united-states.</Citation></Reference><Reference><Citation>Njoku A, Joseph M, Felix R.. Changing the narrative: structural barriers and racial and ethnic inequities in COVID-19 vaccination. Int J Environ Res Public Health. 2021;18(18):9904. doi: 10.3390/ijerph18189904.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18189904</ArticleId><ArticleId IdType="pmc">PMC8470519</ArticleId><ArticleId IdType="pubmed">34574827</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobierajski T, Rzymski P, Wanke-Rytt M.. The influence of recommendation of medical and non-medical authorities on the decision to vaccinate against influenza from a ­social vaccinology perspective: cross-sectional, representative study of Polish Society. Vaccines (Basel). 2023;11(5):994. doi: 10.3390/vaccines11050994.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11050994</ArticleId><ArticleId IdType="pmc">PMC10221997</ArticleId><ArticleId IdType="pubmed">37243098</ArticleId></ArticleIdList></Reference><Reference><Citation>Privor-Dumm L, King T.. Community-based strategies to engage pastors can help address vaccine hesitancy and health disparities in Black communities. J Health Commun. 2020;25(10):827–830. doi: 10.1080/10810730.2021.1873463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10810730.2021.1873463</ArticleId><ArticleId IdType="pubmed">33719889</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W, Kandula S, Huynh M, et al. . Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis. Lancet Infect Dis. 2021;21(2):203–212. doi: 10.1016/S1473-3099(20)30769-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30769-6</ArticleId><ArticleId IdType="pmc">PMC7572090</ArticleId><ArticleId IdType="pubmed">33091374</ArticleId></ArticleIdList></Reference><Reference><Citation>European Centre for Disease Prevention and Control (ECDC). COVID-19 vaccine tracker 2023 [cited 2023 Nov 24]. Available from: https://vaccinetracker.ecdc.europa.eu/public/extensions/COVID-19/vaccine-tracker.html#uptake-tab.</Citation></Reference><Reference><Citation>de Gomensoro E, Del Giudice G, Doherty TM.. Challenges in adult vaccination. Ann Med. 2018;50(3):181–192. doi: 10.1080/07853890.2017.1417632.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2017.1417632</ArticleId><ArticleId IdType="pubmed">29338438</ArticleId></ArticleIdList></Reference><Reference><Citation>Doherty TM, Del Giudice G, Maggi S.. Adult vaccination as part of a healthy lifestyle: moving from medical ­intervention to health promotion. Ann Med. 2019;51(2):128–140. doi: 10.1080/07853890.2019.1588470.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2019.1588470</ArticleId><ArticleId IdType="pmc">PMC7857442</ArticleId><ArticleId IdType="pubmed">31025882</ArticleId></ArticleIdList></Reference><Reference><Citation>Raina MacIntyre C, Menzies R, Kpozehouen E, et al. . Equity in disease prevention: vaccines for the older adults – a national workshop, Australia 2014. Vaccine. 2016;34(46):5463–5469. doi: 10.1016/j.vaccine.2016.09.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2016.09.039</ArticleId><ArticleId IdType="pubmed">27686835</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurley LP, Lindley MC, Harpaz R, et al. . Barriers to the use of herpes zoster vaccine. Ann Intern Med. 2010;152(9):555–560. doi: 10.7326/0003-4819-152-9-201005040-00005.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-152-9-201005040-00005</ArticleId><ArticleId IdType="pubmed">20439573</ArticleId></ArticleIdList></Reference><Reference><Citation>Equils O, Kellogg C, Baden L, et al. . Logistical and structural challenges are the major obstacles for family medicine physicians’ ability to administer adult vaccines. Hum Vaccin Immunother. 2019;15(3):637–642. doi: 10.1080/21645515.2018.1543524.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2018.1543524</ArticleId><ArticleId IdType="pmc">PMC6605729</ArticleId><ArticleId IdType="pubmed">30395771</ArticleId></ArticleIdList></Reference><Reference><Citation>Montag Schafer K, Reidt S.. Assessment of perceived barriers to Herpes Zoster vaccination among geriatric primary care providers. Pharmacy (Basel). 2016;4(4):30. doi: 10.3390/pharmacy4040030.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pharmacy4040030</ArticleId><ArticleId IdType="pmc">PMC5419371</ArticleId><ArticleId IdType="pubmed">28970403</ArticleId></ArticleIdList></Reference><Reference><Citation>Sayed BA, Feyman Y, King KL, et al. . 
Inflation reduction act research series—medicare part D enrollee vaccine use after elimination of cost sharing for recommended vaccines in 2023–2024; [cited 2024 Aug 28]. Available from: https://aspe.hhs.gov/sites/default/files/documents/3854c8f172045f5e5a4e000d1928124d/part-d-covered-vaccines-no-cost-sharing.pdf.</Citation></Reference><Reference><Citation>International Pharmaceutical Federation . An overview of pharmacy’s impact on immunization coverage: a global survey 2020; [cited 2023 Sep 23]. Available from: https://www.fip.org/file/4751.</Citation></Reference><Reference><Citation>International Vaccine Access Center and Morgan State University . Evaluation of Baltimore City Health Department Flu Vaccination in Senior Housing Buildings 2021 [cited 2024 Jan 16]. Available from: https://www.jhsph.edu/ivac/wp-content/uploads/2021/02/Evaluation-of-BCHD-Flu-Vax-In-2020_feb24.pdf.</Citation></Reference><Reference><Citation>Marquez C, Kerkhoff AD, Naso J, et al. . A multi-component, community-based strategy to facilitate COVID-19 ­vaccine uptake among Latinx populations: from theory to practice. PLoS One. 2021;16(9):e0257111. doi: 10.1371/journal.pone.0257111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0257111</ArticleId><ArticleId IdType="pmc">PMC8452046</ArticleId><ArticleId IdType="pubmed">34543291</ArticleId></ArticleIdList></Reference><Reference><Citation>Syed U, Kapera O, Chandrasekhar A, et al. . The role of faith-based organizations in improving vaccination confidence &amp; addressing vaccination disparities to help ­improve vaccine uptake: a systematic review. Vaccines (Basel). 2023;11(2):449. doi: 10.3390/vaccines11020449.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11020449</ArticleId><ArticleId IdType="pmc">PMC9966262</ArticleId><ArticleId IdType="pubmed">36851325</ArticleId></ArticleIdList></Reference><Reference><Citation>Corley AMS, Gomes SM, Crosby LE, et al. . Partnering with faith-based organizations to offer flu vaccination and other preventive services. Pediatrics. 2022;150(3):e2022056193. doi: 10.1542/peds.2022-056193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2022-056193</ArticleId><ArticleId IdType="pubmed">35982030</ArticleId></ArticleIdList></Reference><Reference><Citation>Dada D, Djiometio JN, McFadden SM, et al. . Strategies that promote equity in COVID-19 vaccine uptake for Black communities: a review. J Urban Health. 2022;99(1):15–27. doi: 10.1007/s11524-021-00594-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11524-021-00594-3</ArticleId><ArticleId IdType="pmc">PMC8751469</ArticleId><ArticleId IdType="pubmed">35018612</ArticleId></ArticleIdList></Reference><Reference><Citation>International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Morgan State University . VALUE Baltimore COVAX Education Effort 2023; [cited 2024 Jan 17]. Available from: https://www.jhsph.edu/ivac/wp-content/uploads/2021/10/VALUE-COVAX-Education-Effort-Final-Report-2.21.23-4366.pdf.</Citation></Reference><Reference><Citation>Srivastav A, Black CL, Lutz CS, et al. . U.S. clinicians’ and pharmacists’ reported barriers to implementation of the Standards for Adult Immunization Practice. Vaccine. 2018;36(45):6772–6781. doi: 10.1016/j.vaccine.2018.09.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2018.09.024</ArticleId><ArticleId IdType="pmc">PMC6397956</ArticleId><ArticleId IdType="pubmed">30243501</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans D, Norrbom C, Schmidt S, et al. . Engaging community-based organizations to address barriers in public health programs: lessons learned from COVID-19 vaccine acceptance programs in diverse rural communities. Health Secur. 2023;21(S1):S17–S24. doi: 10.1089/hs.2023.0017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/hs.2023.0017</ArticleId><ArticleId IdType="pmc">PMC10818044</ArticleId><ArticleId IdType="pubmed">37610883</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Castri AM, Halperin DM, Ye L, et al. . Public awareness, attitudes, beliefs, and behaviors regarding the role of pharmacists as immunizers. Hum Vaccin Immunother. 2021;17(9):3052–3065. doi: 10.1080/21645515.2021.1913963.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2021.1913963</ArticleId><ArticleId IdType="pmc">PMC8381788</ArticleId><ArticleId IdType="pubmed">33988486</ArticleId></ArticleIdList></Reference><Reference><Citation>Maryland Manual On-line . Maryland Vaccine Equity Task Force. Maryland State Archive. [cited 2024 Jan 16]. Available from: https://msa.maryland.gov/msa/mdmanual/26excom/html/35vaccine.html.</Citation></Reference><Reference><Citation>Isenor JE, Killen JL, Billard BA, et al. . Impact of pharmacists as immunizers on influenza vaccination coverage in the community-setting in Nova Scotia, Canada: 2013–2015. J Pharm Policy Pract. 2016;9(1):32. doi: 10.1186/s40545-016-0084-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40545-016-0084-4</ArticleId><ArticleId IdType="pmc">PMC5070082</ArticleId><ArticleId IdType="pubmed">27777781</ArticleId></ArticleIdList></Reference><Reference><Citation>Papastergiou J, Folkins C, Li W, et al. . Community pharmacist-administered influenza immunization improves patient access to vaccination. Can Pharm J (Ott). 2014;147(6):359–365. doi: 10.1177/1715163514552557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1715163514552557</ArticleId><ArticleId IdType="pmc">PMC4213255</ArticleId><ArticleId IdType="pubmed">25364353</ArticleId></ArticleIdList></Reference><Reference><Citation>Merks P, Jakubowska M, Drelich E, et al. . The legal ­extension of the role of pharmacists in light of the COVID-19 global pandemic. Res Social Adm Pharm. 2021;17(1):1807–1812. doi: 10.1016/j.sapharm.2020.05.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sapharm.2020.05.033</ArticleId><ArticleId IdType="pmc">PMC7289723</ArticleId><ArticleId IdType="pubmed">32546449</ArticleId></ArticleIdList></Reference><Reference><Citation>Canadian Pharmacists’ Association/Association des pharmaciens du Canada . Injection authority and vaccine administration in pharmacies across Canada 2024; [cited 2024 Aug 22]. Available from: https://www.pharmacists.ca/cpha-ca/assets/File/cpha-on-the-issues/InjectionVaccinationScan_Feb2024_EN.pdf.</Citation></Reference><Reference><Citation>de Almeida LY, Domingues J, Rewa T, et al. . Implementation of the drive-through strategy for COVID-19 vaccination: an experience report. Rev Esc Enferm USP. 2022;56:e20210397. doi: 10.1590/1980-220X-REEUSP-2021-0397en.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1980-220X-REEUSP-2021-0397en</ArticleId><ArticleId IdType="pmc">PMC10353730</ArticleId><ArticleId IdType="pubmed">35579368</ArticleId></ArticleIdList></Reference><Reference><Citation>Alcendor DJ, Juarez PD, Matthews-Juarez P, et al. . Meharry Medical College Mobile Vaccination Program: implications for increasing COVID-19 vaccine uptake among minority communities in Middle Tennessee. Vaccines (Basel). 2022;10(2):211. doi: 10.3390/vaccines10020211.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10020211</ArticleId><ArticleId IdType="pmc">PMC8878662</ArticleId><ArticleId IdType="pubmed">35214670</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta PS, Mohareb AM, Valdes C, et al. . Expanding COVID-19 vaccine access to underserved populations through implementation of mobile vaccination units. Prev Med. 2022;163:107226. doi: 10.1016/j.ypmed.2022.107226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ypmed.2022.107226</ArticleId><ArticleId IdType="pmc">PMC9404072</ArticleId><ArticleId IdType="pubmed">36029925</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambooij M, Pijpers J, van de Kassteele J, et al. . 
The effect of mobile vaccination units on vaccine uptake with COVID-19 vaccines: a within-neighbourhood analysis using National Registration Data. Lancet. 2023; https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4546773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11367067</ArticleId><ArticleId IdType="pubmed">39176986</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Tulloch JSP, Knott S, et al. . Evaluating the impact of using mobile vaccination units to increase COVID-19 vaccination uptake in Cheshire and Merseyside, UK: a synthetic control analysis. BMJ Open. 2023;13(10):e071852. doi: 10.1136/bmjopen-2023-071852.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2023-071852</ArticleId><ArticleId IdType="pmc">PMC10565187</ArticleId><ArticleId IdType="pubmed">37802621</ArticleId></ArticleIdList></Reference><Reference><Citation>Gharpure R, Guo A, Bishnoi CK, et al. Early COVID-19 first-dose vaccination coverage among residents and staff members of skilled nursing facilities participating in the pharmacy partnership for long-term care program - United States, December 2020-January 2021. MMWR Morb Mortal Wkly Rep. 2021;70(5):178–182. doi: 10.15585/mmwr.mm7005e2.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7005e2</ArticleId><ArticleId IdType="pmc">PMC7861479</ArticleId><ArticleId IdType="pubmed">33539332</ArticleId></ArticleIdList></Reference><Reference><Citation>Griswold AR, Klein J, Dusaj N, et al. . Students as community vaccinators: implementation of a service-learning COVID-19 vaccination program. Vaccines (Basel). 2022;10(7):1058. doi: 10.3390/vaccines10071058.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10071058</ArticleId><ArticleId IdType="pmc">PMC9324302</ArticleId><ArticleId IdType="pubmed">35891222</ArticleId></ArticleIdList></Reference><Reference><Citation>Association of Immunization Managers, National Association of School Nurses . Key challenges and opportunities for implementing school-located vaccination clinics for COVID-19 and influenza: roundtables with school nurses and immunization programs. NASN Sch Nurse. 2022;37(1_suppl):15S–23S. doi: 10.1177/1942602X211064752.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1942602X211064752</ArticleId><ArticleId IdType="pubmed">34974774</ArticleId></ArticleIdList></Reference><Reference><Citation>Litaker JR, Tamez N, Durkalski W, et al. . Using Health Insurance Network provider data and public data sets to identify SARS-CoV-2 vaccinators in the USA. Front Public Health. 2021;8:616140. doi: 10.3389/fpubh.2020.616140.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2020.616140</ArticleId><ArticleId IdType="pmc">PMC7873732</ArticleId><ArticleId IdType="pubmed">33585386</ArticleId></ArticleIdList></Reference><Reference><Citation>Anson R, Willcott A, Toperoff W, et al. . COVID-19 telemedicine and vaccination at an urban safety Net HIV medicine clinic. J Nurse Pract. 2022;18(8):837–840. doi: 10.1016/j.nurpra.2022.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nurpra.2022.06.005</ArticleId><ArticleId IdType="pmc">PMC9274297</ArticleId><ArticleId IdType="pubmed">35844811</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdul-Mutakabbir JC, Casey S, Jews V, et al. . A three-tiered approach to address barriers to COVID-19 vaccine delivery in the Black community. Lancet Glob Health. 2021;9(6):e749–e750. doi: 10.1016/S2214-109X(21)00099-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(21)00099-1</ArticleId><ArticleId IdType="pmc">PMC7946412</ArticleId><ArticleId IdType="pubmed">33713634</ArticleId></ArticleIdList></Reference><Reference><Citation>Adeagbo M, Olukotun M, Musa S, et al. . Improving COVID-19 vaccine uptake among Black populations: a systematic review of strategies. Int J Environ Res Public Health. 2022;19(19):11971. doi: 10.3390/ijerph191911971.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191911971</ArticleId><ArticleId IdType="pmc">PMC9565689</ArticleId><ArticleId IdType="pubmed">36231270</ArticleId></ArticleIdList></Reference><Reference><Citation>Swope M, Alem AC, Russo SC, et al. . Developing a community-oriented and place-based strategy to improve COVID-19 vaccine accessibility. Perm J. 2023;27(1):103–112. doi: 10.7812/TPP/22.097.</Citation><ArticleIdList><ArticleId IdType="doi">10.7812/TPP/22.097</ArticleId><ArticleId IdType="pmc">PMC10015609</ArticleId><ArticleId IdType="pubmed">36911890</ArticleId></ArticleIdList></Reference><Reference><Citation>Baltimore City . Baltimore City COVID-19 vaccination dashboard 2023; [cited 2024 Jan 17]. Available from: https://www.arcgis.com/apps/dashboards/eb70624fe27c4a86a45dbcb4cf89ccb2.</Citation></Reference><Reference><Citation>Eiden AL, Barratt J, Nyaku MK.. A review of factors ­influencing vaccination policies and programs for older adults globally. Hum Vaccin Immunother. 2023;19(1):2157164.doi: 10.1080/21645515.2022.2157164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2022.2157164</ArticleId><ArticleId IdType="pmc">PMC9980618</ArticleId><ArticleId IdType="pubmed">36656057</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapienza A, Falcone R.. The role of trust in COVID-19 vaccine acceptance: considerations from a systematic review. Int J Environ Res Public Health. 2022;20(1):665. doi: 10.3390/ijerph20010665.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph20010665</ArticleId><ArticleId IdType="pmc">PMC9819668</ArticleId><ArticleId IdType="pubmed">36612982</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngo VM, Zimmermann KF, Nguyen PV, et al. . How education and GDP drive the COVID-19 vaccination campaign. Arch Public Health. 2022;80(1):171. doi: 10.1186/s13690-022-00924-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13690-022-00924-0</ArticleId><ArticleId IdType="pmc">PMC9289083</ArticleId><ArticleId IdType="pubmed">35850775</ArticleId></ArticleIdList></Reference><Reference><Citation>Jennings W, Valgarðsson V, McKay L, et al. . Trust and vaccine hesitancy during the COVID-19 pandemic: a cross-national analysis. Vaccine X. 2023;14:100299. doi: 10.1016/j.jvacx.2023.100299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvacx.2023.100299</ArticleId><ArticleId IdType="pmc">PMC10079319</ArticleId><ArticleId IdType="pubmed">37063307</ArticleId></ArticleIdList></Reference><Reference><Citation>Nazari A, Hoseinnia M, Pirzadeh A, et al. . The correlation among COVID-19 vaccine acceptance, the ability to ­detect fake news, and e-Health literacy. Health Lit Res Pract. 2023;7(3):e130–e138. doi: 10.3928/24748307-20230621-01.</Citation><ArticleIdList><ArticleId IdType="doi">10.3928/24748307-20230621-01</ArticleId><ArticleId IdType="pmc">PMC10351963</ArticleId><ArticleId IdType="pubmed">37463291</ArticleId></ArticleIdList></Reference><Reference><Citation>Fenta ET, Tiruneh MG, Delie AM, et al. . Health literacy and COVID-19 vaccine acceptance worldwide: a systematic review. SAGE Open Med. 2023;11:20503121231197869. doi: 10.1177/20503121231197869.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20503121231197869</ArticleId><ArticleId IdType="pmc">PMC10563502</ArticleId><ArticleId IdType="pubmed">37823070</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention . Place of influenza vaccination among adults – United States, 2010–11 influenza season. MMWR Morb Mortal Wkly Rep. 2011;60(23):781–785.</Citation><ArticleIdList><ArticleId IdType="pubmed">21681175</ArticleId></ArticleIdList></Reference><Reference><Citation>University of Maryland School of Public Health . Shots at the Shop 2024; [cited 2024 Jan 17]. Available from: https://sph.umd.edu/shotsattheshop.</Citation></Reference><Reference><Citation>Taylor NK, Faulks M, Brown-Johnson CG, et al. . Pandemic through the lens of Black Barbershops: COVID-19’s impact and Barbers’ potential role as Public Health extenders. J Immigr Minor Health. 2023;25(3):660–665. doi: 10.1007/s10903-022-01420-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10903-022-01420-x</ArticleId><ArticleId IdType="pmc">PMC9684895</ArticleId><ArticleId IdType="pubmed">36417031</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz B, Brewer J, Budigan H, et al. . Factors affecting SARS-CoV-2 vaccination intent and decision making among African American, Native American, and Hispanic participants in a qualitative study. Public Health Rep. 2023;138(3):422–427. doi: 10.1177/00333549231160871.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/00333549231160871</ArticleId><ArticleId IdType="pmc">PMC10050994</ArticleId><ArticleId IdType="pubmed">36971286</ArticleId></ArticleIdList></Reference><Reference><Citation>Hattingh HL, Sim TF, Parsons R, et al. . Evaluation of the first pharmacist-administered vaccinations in Western Australia: a mixed-methods study. BMJ Open. 2016;6(9):e011948. doi: 10.1136/bmjopen-2016-011948.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2016-011948</ArticleId><ArticleId IdType="pmc">PMC5051390</ArticleId><ArticleId IdType="pubmed">27650763</ArticleId></ArticleIdList></Reference><Reference><Citation>IQVIA . Trends in Vaccine Administration in the United States 2023; [cited 2023 Sep 6]. Available from: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/trends-in-vaccine-administration-in-the-united-states.</Citation></Reference><Reference><Citation>Goad JA, Taitel MS, Fensterheim LE, et al. . Vaccinations administered during off-clinic hours at a national community pharmacy: implications for increasing patient access and convenience. Ann Fam Med. 2013;11(5):429–436. doi: 10.1370/afm.1542.</Citation><ArticleIdList><ArticleId IdType="doi">10.1370/afm.1542</ArticleId><ArticleId IdType="pmc">PMC3767711</ArticleId><ArticleId IdType="pubmed">24019274</ArticleId></ArticleIdList></Reference><Reference><Citation>UK Health Security Agency . Seasonal influenza vaccine uptake in GP patients. Winter season 2021 to 2022; [cited 2023 Nov 14]. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1176794/GP-patients-flu-annual-report-2021-to-2022-corrected_final.pdf.</Citation></Reference><Reference><Citation>Finnegan G.
Does pharmacy vaccination increase overall uptake?
2018; [cited 2023 Sep 6]. Available from: https://www.vaccinestoday.eu/stories/does-pharmacy-vaccination-increase-overall-uptake/.</Citation></Reference><Reference><Citation>Le LM, Veettil SK, Donaldson D, et al. . The impact of pharmacist involvement on immunization uptake and other outcomes: an updated systematic review and meta-analysis. J Am Pharm Assoc (2003). 2022;62(5):1499–1513.e16. doi: 10.1016/j.japh.2022.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.japh.2022.06.008</ArticleId><ArticleId IdType="pmc">PMC9448680</ArticleId><ArticleId IdType="pubmed">35961937</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchan SA, Rosella LC, Finkelstein M, et al. . Impact of pharmacist administration of influenza vaccines on ­uptake in Canada. CMAJ. 2017;189(4):E146–E152. doi: 10.1503/cmaj.151027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.151027</ArticleId><ArticleId IdType="pmc">PMC5266568</ArticleId><ArticleId IdType="pubmed">27503864</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheikh S, Biundo E, Courcier S, et al. . A report on the status of vaccination in Europe. Vaccine. 2018;36(33):4979–4992. doi: 10.1016/j.vaccine.2018.06.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2018.06.044</ArticleId><ArticleId IdType="pubmed">30037416</ArticleId></ArticleIdList></Reference><Reference><Citation>Blank P, Schwenkglenks M, Szucs TD.. The impact of European vaccination policies on seasonal influenza vaccination coverage rates in the elderly. Hum Vaccin Immunother. 2012;8(3):328–335. doi: 10.4161/hv.18629.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/hv.18629</ArticleId><ArticleId IdType="pubmed">22327498</ArticleId></ArticleIdList></Reference><Reference><Citation>Palache A, Oriol-Mathieu V, Abelin A, et al. . Seasonal influenza vaccine dose distribution in 157 countries (2004–2011). Vaccine. 2014;32(48):6369–6376. doi: 10.1016/j.vaccine.2014.07.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2014.07.012</ArticleId><ArticleId IdType="pubmed">25442403</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortiz JR, Perut M, Dumolard L, et al. . A global review of national influenza immunization policies: analysis of the 2014 WHO/UNICEF Joint Reporting Form on immunization. Vaccine. 2016;34(45):5400–5405. doi: 10.1016/j.vaccine.2016.07.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2016.07.045</ArticleId><ArticleId IdType="pmc">PMC5357765</ArticleId><ArticleId IdType="pubmed">27646030</ArticleId></ArticleIdList></Reference><Reference><Citation>Dotlic J, Jeremic Stojkovic V, Cummins P, et al. . Enhancing COVID-19 vaccination coverage using financial incentives: arguments to help health providers counterbalance erroneous claims. Epidemiol Health. 2021;43:e2021081. doi: 10.4178/epih.e2021081.</Citation><ArticleIdList><ArticleId IdType="doi">10.4178/epih.e2021081</ArticleId><ArticleId IdType="pmc">PMC8859513</ArticleId><ArticleId IdType="pubmed">34645203</ArticleId></ArticleIdList></Reference><Reference><Citation>Blank PR, van Essen GA, Ortiz de Lejarazu R, et al. . Impact of European vaccination policies on seasonal influenza vaccination coverage rates: an update seven years later. Hum Vaccin Immunother. 2018;14(11):2706–2714. doi: 10.1080/21645515.2018.1489948.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2018.1489948</ArticleId><ArticleId IdType="pmc">PMC6314402</ArticleId><ArticleId IdType="pubmed">29923782</ArticleId></ArticleIdList></Reference><Reference><Citation>Zwaagstra Salvado E, van Elten HJ, van Raaij EM.. The linkages between reimbursement and prevention: a mixed-methods approach. Front Public Health. 2021;9:750122. doi: 10.3389/fpubh.2021.750122.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2021.750122</ArticleId><ArticleId IdType="pmc">PMC8578935</ArticleId><ArticleId IdType="pubmed">34778183</ArticleId></ArticleIdList></Reference><Reference><Citation>Merilind E, Salupere R, Västra K, et al. . The influence of performance-based payment on childhood immunization coverage. Health Policy. 2015;119(6):770–777. doi: 10.1016/j.healthpol.2015.01.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.healthpol.2015.01.015</ArticleId><ArticleId IdType="pubmed">25686796</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S. Department of Health and Human Sciences . National Adult Immunization Plan 2018; [cited 2023 Oct 16]. Available from: https://www.hhs.gov/sites/default/files/nvpo/national-adult-immunization-plan/naip.pdf.</Citation></Reference><Reference><Citation>Baratin D, Del Signore C, Thierry J, et al. . Evaluation of adult dTPaP vaccination coverage in France: experience in Lyon city, 2010–2011. BMC Public Health. 2012;12(1):940. doi: 10.1186/1471-2458-12-940.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2458-12-940</ArticleId><ArticleId IdType="pmc">PMC3526515</ArticleId><ArticleId IdType="pubmed">23114050</ArticleId></ArticleIdList></Reference><Reference><Citation>Derrough T, Olsson K, Gianfredi V, et al. . Immunization Information Systems – useful tools for monitoring vaccination programmes in EU/EEA countries, 2016. Euro Surveill. 2017;22(17):30519. doi: 10.2807/1560-7917.ES.2017.22.17.30519.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2017.22.17.30519</ArticleId><ArticleId IdType="pmc">PMC5434883</ArticleId><ArticleId IdType="pubmed">28488999</ArticleId></ArticleIdList></Reference><Reference><Citation>Groom H, Hopkins DP, Pabst LJ, et al. . Immunization information systems to increase vaccination rates: a community guide systematic review. J Public Health Manag Pract. 2015;21(3):227–248. doi: 10.1097/PHH.0000000000000069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PHH.0000000000000069</ArticleId><ArticleId IdType="pubmed">24912082</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobson Vann JC, Jacobson RM, Coyne-Beasley T, et al. . Patient reminder and recall interventions to improve ­immunization rates. Cochrane Database Syst Rev. 2018;1(1):CD003941. doi: 10.1002/14651858.CD003941.pub3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD003941.pub3</ArticleId><ArticleId IdType="pmc">PMC6491344</ArticleId><ArticleId IdType="pubmed">29342498</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas RE, Lorenzetti DL.. Interventions to increase influenza vaccination rates of those 60 years and older in the community. Cochrane Database Syst Rev. 2018;5(5):CD005188. doi: 10.1002/14651858.CD005188.pub4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD005188.pub4</ArticleId><ArticleId IdType="pmc">PMC6494593</ArticleId><ArticleId IdType="pubmed">29845606</ArticleId></ArticleIdList></Reference><Reference><Citation>Drozd EM, Miller L, Johnsrud M.. Impact of Pharmacist Immunization Authority on seasonal influenza immunization rates across states. Clin Ther. 2017;39(8):1563–1580 e17. doi: 10.1016/j.clinthera.2017.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2017.07.004</ArticleId><ArticleId IdType="pubmed">28781217</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaplan-Weisman L, Waltermaurer E, Crump C.. Assessing and improving Zoster vaccine uptake in a homeless population. J Community Health. 2018;43(6):1019–1027. doi: 10.1007/s10900-018-0517-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10900-018-0517-x</ArticleId><ArticleId IdType="pubmed">29730833</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanchi S, Vaux J, Toqué JM, et al. . Impact of a catch-up strategy of DT-IPV vaccination during hospitalization on vaccination coverage among people over 65 years of age in France: the HOSPIVAC Study (Vaccination during Hospitalization). Vaccines (Basel). 2020;8(2):292. doi: 10.3390/vaccines8020292.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines8020292</ArticleId><ArticleId IdType="pmc">PMC7349959</ArticleId><ArticleId IdType="pubmed">32527049</ArticleId></ArticleIdList></Reference><Reference><Citation>Canadian Midwives. Vaccines 2024 . [cited 2024 Aug 22]. Available from: https://canadianmidwives.org/vaccines/.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>